InsidersTradesSigma
Explore the complete record of transactions filed by Rosenberger Brian, Vice-Président. Director active across 1 companies, notably Zynerba Pharmaceuticals, Inc.. In total, 2 reports have been logged. The latest transaction was filed on 26 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Brian Rosenberger is the Vice President of Commercial and Business Development at Zynerba Pharmaceuticals, Inc. In this role, he is responsible for managing business relationships and expanding the company's operations. His expertise is essential for the commercial success of the organization.